Literature DB >> 20538323

MDM2 SNP 309 human papillomavirus infection in cervical carcinogenesis.

Osamu Nunobiki1, Masatsugu Ueda, Michiko Yamamoto, Eisaku Toji, Naomi Sato, Shinji Izuma, Yoshiaki Okamoto, Kiyo Torii, Sadamu Noda.   

Abstract

OBJECTIVE: To investigate the biological significance of single nucleotide polymorphism (SNP) at murine double-minute 2 homolog (MDM2) promoter 309 in cervical carcinogenesis.
METHODS: SNP at MDM2 promoter 309 (T/G) together with human papillomavirus (HPV) types was examined in a total of 195 cervical smear samples and 8 human cervical squamous carcinoma cell lines using two independent PCR assays and PCR-RFLP techniques.
RESULTS: Forty-one patients with high-grade squamous intraepithelial lesion (HSIL) had higher frequency of high-risk HPV than 102 with low-grade SIL (LSIL) and 52 controls. There was an increased OR (8.88; CI=2.34-33.63; P=0.003) for TG+GG genotype in HSIL cases compared to controls among 68 patients with high-risk HPV. Twenty-one cases with HPV types 16 and/or 18 had significantly higher frequency of the TG+GG genotype and G allele than 47 with other types of high-risk HPV. Seven of 8 cervical carcinoma cell lines also showed TG or GG genotype.
CONCLUSION: MDM2-SNP309 (T/G) and high-risk HPV infection may be closely associated with cervical carcinogenesis in a Japanese population. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538323     DOI: 10.1016/j.ygyno.2010.05.009

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Clinical significance of hWAPL polymorphisms in the risk of cervical carcinogenesis.

Authors:  Osamu Nunobiki; Daisuke Sano; Sakae Hata; Toshitada Ogasawara; Masatsugu Ueda
Journal:  Hum Cell       Date:  2018-01-23       Impact factor: 4.174

2.  GSTM1, GSTT1, and NQO1 polymorphisms in cervical carcinogenesis.

Authors:  Osamu Nunobiki; Masatsugu Ueda; Hikari Akise; Shinji Izuma; Kiyo Torii; Yoshiaki Okamoto; Ichiro Tanaka; Sadamu Noda; Kyoko Akashi; Taro Higashida
Journal:  Hum Cell       Date:  2015-02-20       Impact factor: 4.174

Review 3.  Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes.

Authors:  Shing Cheng Tan; Ravindran Ankathil
Journal:  Tumour Biol       Date:  2015-08-05

4.  MDM2 SNP309 variation increases cervical cancer risk among Asians.

Authors:  Xianlu Zhuo; Jie Ren; Dairong Li; Yongzhong Wu; Qi Zhou
Journal:  Tumour Biol       Date:  2014-02-15

5.  Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review.

Authors:  Meijia Yu; Qin Zhang; Xia Zhao
Journal:  Front Oncol       Date:  2022-08-19       Impact factor: 5.738

6.  Murine Double-Minute 2 Homolog Single Nucleotide Polymorphisms 285 and 309 in Cervical Carcinogenesis.

Authors:  Andrzej Roszak; Matthew Misztal; Anna Sowińska; Pawel P Jagodziński
Journal:  Mol Diagn Ther       Date:  2015-08       Impact factor: 4.074

7.  MDM2 polymorphism associated with the development of cervical lesions in women infected with Human papillomavirus and using of oral contraceptives.

Authors:  Carolina Mm Amaral; Katerina Cetkovská; Ana Pad Gurgel; Marcus V Cardoso; Bárbara S Chagas; Sérgio Sl Paiva Júnior; Rita de Cássia Pereira de Lima; Jacinto C Silva-Neto; Luiz Af Silva; Maria Tc Muniz; Valdir Q Balbino; Antonio C Freitas
Journal:  Infect Agent Cancer       Date:  2014-07-18       Impact factor: 2.965

8.  Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk: A MOOSE-compliant meta-analysis.

Authors:  Xiaohua Duan; Jingquan Li
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.